Suhail Razak

2.9k total citations
134 papers, 1.9k citations indexed

About

Suhail Razak is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Suhail Razak has authored 134 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 25 papers in Pathology and Forensic Medicine and 19 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Suhail Razak's work include Chemotherapy-induced organ toxicity mitigation (14 papers), Reproductive Biology and Fertility (10 papers) and Diet and metabolism studies (7 papers). Suhail Razak is often cited by papers focused on Chemotherapy-induced organ toxicity mitigation (14 papers), Reproductive Biology and Fertility (10 papers) and Diet and metabolism studies (7 papers). Suhail Razak collaborates with scholars based in Saudi Arabia, Pakistan and United States. Suhail Razak's co-authors include Tayyaba Afsar, Ali Almajwal, Muhammad Rashid Khan, Sarwat Jahan, Mahmoud M. A. Abulmeaty, Maria Shabbir, Qurat Ul Ain, Dara Aldisi, Ghazala Shaheen and Hizb Ullah and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Suhail Razak

117 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suhail Razak Saudi Arabia 24 404 299 292 276 234 134 1.9k
Tayyaba Afsar Saudi Arabia 22 364 0.9× 282 0.9× 272 0.9× 226 0.8× 206 0.9× 105 1.6k
Seval Yılmaz Türkiye 22 373 0.9× 264 0.9× 490 1.7× 425 1.5× 239 1.0× 69 2.3k
Osman Çiftçi Türkiye 27 412 1.0× 269 0.9× 406 1.4× 333 1.2× 223 1.0× 108 2.1k
Aslı Çetin Türkiye 24 391 1.0× 185 0.6× 467 1.6× 244 0.9× 273 1.2× 98 1.9k
Cevat Aktaş Türkiye 26 340 0.8× 334 1.1× 170 0.6× 219 0.8× 158 0.7× 45 1.8k
Mustafa Erboğa Türkiye 26 377 0.9× 226 0.8× 202 0.7× 210 0.8× 118 0.5× 49 1.8k
Selim Çomaklı Türkiye 26 417 1.0× 137 0.5× 293 1.0× 323 1.2× 131 0.6× 82 1.9k
Mustafa Özkaraca Türkiye 21 306 0.8× 103 0.3× 196 0.7× 254 0.9× 113 0.5× 99 1.8k
Ali Osman Çeribaşı Türkiye 22 330 0.8× 533 1.8× 778 2.7× 488 1.8× 417 1.8× 49 2.3k
Adel R. A. Abd‐Allah Egypt 25 583 1.4× 143 0.5× 157 0.5× 124 0.4× 105 0.4× 63 1.7k

Countries citing papers authored by Suhail Razak

Since Specialization
Citations

This map shows the geographic impact of Suhail Razak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suhail Razak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suhail Razak more than expected).

Fields of papers citing papers by Suhail Razak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suhail Razak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suhail Razak. The network helps show where Suhail Razak may publish in the future.

Co-authorship network of co-authors of Suhail Razak

This figure shows the co-authorship network connecting the top 25 collaborators of Suhail Razak. A scholar is included among the top collaborators of Suhail Razak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suhail Razak. Suhail Razak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Shabbir, Maria, et al.. (2025). Inherited metabolic disorders: presentation, clinical types, laboratory diagnosis and genetic markers. Orphanet Journal of Rare Diseases. 20(1). 422–422. 1 indexed citations
3.
Ali, Shaukat, Asim Pervaiz, Khushbukhat Khan, et al.. (2025). Sericin-chitosan conjugated silver nanoparticles protect against 1,2-dimethylhydrazine-induced colon cancer in mice by regulating metastatic biomarkers, prohibiting dysplasia and enhancing antioxidant potential. International Journal of Biological Macromolecules. 321(Pt 3). 146478–146478. 1 indexed citations
4.
Shabbir, Maria, Khushbukhat Khan, Janeen H. Trembley, et al.. (2024). Possible prognostic impact of PKCι genetic variants in prostate cancer. Cancer Cell International. 24(1). 24–24. 1 indexed citations
5.
Aslam, Tariq, Muhammad Omer Iqbal, Umair Khalil, et al.. (2024). Discovering the anti-diabetic potential of pomegranate peel metabolites by examining molecular interplay with the thioredoxin-interacting protein. Frontiers in Medicine. 10. 1322450–1322450. 2 indexed citations
7.
Khurshid, Ahmat, et al.. (2024). Photoactive metabolite mediated photodynamic therapy of Rhabdomyosarcoma cell lines using medicinal plants and Doxorubicin co-treatments. BMC Complementary Medicine and Therapies. 24(1). 270–270. 1 indexed citations
8.
Khan, Khushbukhat, Naeem Mahmood Ashraf, Yasmin Badshah, et al.. (2024). Genetic Variants at PRKCG Splice and UTR Sites Promote Cancer Susceptibility by Disrupting Epigenetic and miRNA Regulatory Network. Journal of Cancer. 15(20). 6644–6657.
9.
Ijaz, Muhammad Umar, et al.. (2024). Apigetrin ameliorates doxorubicin prompted testicular damage: biochemical, spermatological and histological based study. Scientific Reports. 14(1). 9049–9049. 3 indexed citations
10.
Shabbir, Maria, Yasmin Badshah, Khushbukhat Khan, et al.. (2023). Elucidating the role of missense SNP of protein kinase C epsilon in HCV-induced hepatocellular carcinoma. BMC Cancer. 23(1). 147–147. 2 indexed citations
12.
Khan, Khushbukhat, Yasmin Badshah, Naeem Mahmood Ashraf, et al.. (2023). Pathogenicity of PKCγ Genetic Variants—Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer. Genes. 14(1). 236–236. 2 indexed citations
13.
Afsar, Tayyaba, Ahmed Waqas, Safdar Abbas, et al.. (2023). A Novel Variant in the PAX4 Gene Causes Maturity-Onset Diabetes of the Young (MODY), Type IX with Neurodevelopmental Disorder. SHILAP Revista de lepidopterología. 2(2).
14.
Abulmeaty, Mahmoud M. A., et al.. (2023). Inflammatory Cytokines, Redox Status, and Cardiovascular Diseases Risk after Weight Loss via Bariatric Surgery and Lifestyle Intervention. Medicina. 59(4). 751–751. 7 indexed citations
15.
Jahan, Sarwat, Tayyaba Afsar, Ali Almajwal, et al.. (2023). Analyzing the Differential Impact of Semen Preparation Methods on the Outcomes of Assisted Reproductive Techniques. Biomedicines. 11(2). 467–467. 7 indexed citations
17.
Alam, Iftikhar, Ali Almajwal, Ibrar Alam, et al.. (2019). The immune-nutrition interplay in aging – facts and controversies. 5(2). 73–95. 16 indexed citations
18.
Jahan, Sarwat, et al.. (2017). Protective effects of GABA against metabolic and reproductive disturbances in letrozole induced polycystic ovarian syndrome in rats. Journal of Ovarian Research. 10(1). 62–62. 36 indexed citations
19.
Vanaja, M., G. R. Maruthi Sankar, M. Maheswari, et al.. (2015). Genotypic variation for growth and yield response at two elevated levels of CO2 and three seasons in blackgram (Vigna mungo). The Indian Journal of Agricultural Sciences. 85(3). 321–330.
20.
Razak, Suhail, et al.. (2015). Early Diagnosis of Typhoid By PCR For FliC-d Gene of Salmonella Typhi in Patients Taking Antibiotics.. PubMed. 25(9). 662–6. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026